Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 2 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Inhibition of galectins in cancer: Biological challenges for their clinical application.
Front Immunol. 2023 Jan 10;13:1104625. doi: 10.3389/fimmu.2022.1104625. eCollection 2022.
Front Immunol. 2023.
PMID: 36703969
Free PMC article.
Review.
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.
Laderach DJ, Compagno D.
Laderach DJ, et al.
Cancers (Basel). 2021 Sep 9;13(18):4529. doi: 10.3390/cancers13184529.
Cancers (Basel). 2021.
PMID: 34572756
Free PMC article.
Review.
Item in Clipboard
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials.
Compagno D, Tiraboschi C, Garcia JD, Rondón Y, Corapi E, Velazquez C, Laderach DJ.
Compagno D, et al. Among authors: laderach dj.
Biomolecules. 2020 May 12;10(5):750. doi: 10.3390/biom10050750.
Biomolecules. 2020.
PMID: 32408492
Free PMC article.
Review.
Item in Clipboard
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome.
Tiraboschi C, Gentilini L, Velazquez C, Corapi E, Jaworski FM, Garcia Garcia JD, Rondón Y, Chauchereau A, Laderach DJ, Compagno D.
Tiraboschi C, et al. Among authors: laderach dj.
J Immunother Cancer. 2020 Dec;8(2):e001535. doi: 10.1136/jitc-2020-001535.
J Immunother Cancer. 2020.
PMID: 33293356
Free PMC article.
Item in Clipboard
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.
Gentilini LD, Jaworski FM, Tiraboschi C, Pérez IG, Kotler ML, Chauchereau A, Laderach DJ, Compagno D.
Gentilini LD, et al. Among authors: laderach dj.
Oncotarget. 2017 Jul 4;8(27):44654-44668. doi: 10.18632/oncotarget.17963.
Oncotarget. 2017.
PMID: 28591719
Free PMC article.
Item in Clipboard
Cite
Cite